SARS-CoV-2 BA.1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodiesSabrina Lusvarghi, Carol D. Weiss, Brian K. Agan et al.|Science Translational Medicine|2022Cited by 94
Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 InfectionStephanie A Richard, K Lago, Simon Pollett et al.|JAMA Network Open|2023Cited by 91
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination historyWei Wang, Carol D. Weiss, Sabrina Lusvarghi et al.|Cell Host & Microbe|2022Cited by 72
Type‐specific clinical characteristics of adenovirus‐associated influenza‐like illness at five <scp>US</scp> military medical centers, 2009–2014Michael Koren, Eugene V. Millar, John Arnold et al.|Influenza and Other Respiratory Viruses|2016Cited by 17